Saturday, April 19, 2025
29.4 C
Bengaluru

Winning Sales Organization

[wpfilebase tag=file id=101 tpl=download-button /]

Inside this Issue

1. Rudyard Kipling and the Pharma Brand Plan  by  Vivek Hattangadi

The wisdom of the renown English poet applied to pharma brand planning

2. What Does Digitilization Mean to You? by Hanno Wolfram

A look at the impact of digital at every step of the healthcare value chaint 

3. Selling in a Digital Era by Salil Kallianpuri

The right message, to the right customer, at the right frequency, through the right channels 

4. OPPI 51 AGM Highlights  by K. Hariram

Reporting

5. AIOCD Market Highlights  by Ameesh Masurekar

Market highlights for the month of November 2017

Download the issue here: PDF

Hot this week

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

Rx 2024 – Top 25 Drugs by Sales, Growth & Market Trends

The pharmaceutical market in 2024 saw major shifts driven...

India’s Medical Devices Market: Strategic Implications and Key Investors

KKR's Investments in India's Medical Devices Market: Strategic Implications...

Topics

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

Rx 2024 – Top 25 Drugs by Sales, Growth & Market Trends

The pharmaceutical market in 2024 saw major shifts driven...

India’s Medical Devices Market: Strategic Implications and Key Investors

KKR's Investments in India's Medical Devices Market: Strategic Implications...

Top 25 Indian Pharma Companies by Revenues in 2024

India pharma is crucial for global healthcare, providing affordable...

Top 10 Indian Pharma – 2025

India's top 10 pharma companies by market capitalization, offering insights into...

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

1. Market Overview The oncology sector remains the most dominant...
spot_img

Related Articles

spot_imgspot_img